Online customer service
Customer service hotline
0713-6515156
Online service
QQ:
QQ:
Service time:
0:00 - 24:00

6.5%Neomycin Sulfate Soluble Powder

编号
没有此类产品
Description

 

Neomycin Sulfate soluble powder

 

 


6.5%肠炎欣.jpg

 

 

 

 

一、Product name:

Neomycin Sulfate soluble powder

 

二、Specification:

6.5%、32.5%

 

三、Descriptions of Neomycin Sulfate soluble powder:

Pharmacodynamics:

Neomycin is an aminoglycoside antibiotic. It acts on the bacteria ribosome, inhibiting the synthesis of protein, strengthening cell membrane permeability, which causes the leakage of some important cell materials such as potassium ion, adenine and nucleotide, leading to the death of the cells. Neomycin is especially effective to the bacteria in rest stage. It has good antibacterial function on staphylococcus aureus and enterobacteriaceae (coli etc.). The bacteria may obtain resistance to neomycin, but the process is slow. There is also partial or complete cross-resistance between neomycin and streptomycin, kanamycin, or gentamicin.

 

Pharmacokinetics:

Little of neomycin is absorbed if orally or locally applied. When orally applied, only 3% is excreted with urine and most is excreted with dejecta in original shape. A large amount can be absorbed when there is intestinal inflammation or abscess. 

 

Advantage:

1、No toxic residue, convenient and safe use.

2、quick response with better effect.

3、Quickly remove intestinal toxins, improve the body resistance to prevent disease recurrence.

 

 

四、Indications:

It is indicated for the prevention and treatment of bacterial enteritis in calves, sheep, goats, swine and poultry caused by bacteria susceptible to neomycin, such as E. coli, Salmonella and Campylobacter spp.

 

五、Usage and dosage:

take 6.5% specification for example.

Water-premix: poultry—200g-300g product/1 ton water, successive for 3-5 days.

 

Warning:Keep out of reach of children.

 

Corresponding parameter set not found, please add it in property template of background
暂未实现,敬请期待
暂未实现,敬请期待
Previous article
Next article